Atlas Trials

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

Clinical trial NCT04858412 · RECRUITING

Trial details

NCT number
NCT04858412
Sponsor
The Cleveland Clinic
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Alcoholic Liver DiseaseCOVID 19 Pneumonia
Start date
2021-04-01
Primary completion
2026-12-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.